M, A., S, M., F, H., A, Z., A, Z., H, S., . . . S, S. (2026). Retraction notice to "New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities" [Biomedicine & Pharmacotherapy 141 (2021) 111824]. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 198, 119228. https://doi.org/10.1016/j.biopha.2026.119228
Chicago Style (17th ed.) CitationM, Ashrafizadeh, et al. "Retraction Notice to "New Insight Towards Development of Paclitaxel and Docetaxel Resistance in Cancer Cells: EMT as a Novel Molecular Mechanism and Therapeutic Possibilities" [Biomedicine & Pharmacotherapy 141 (2021) 111824]." Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 198 (2026): 119228. https://doi.org/10.1016/j.biopha.2026.119228.
MLA (9th ed.) CitationM, Ashrafizadeh, et al. "Retraction Notice to "New Insight Towards Development of Paclitaxel and Docetaxel Resistance in Cancer Cells: EMT as a Novel Molecular Mechanism and Therapeutic Possibilities" [Biomedicine & Pharmacotherapy 141 (2021) 111824]." Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, vol. 198, 2026, p. 119228, https://doi.org/10.1016/j.biopha.2026.119228.
